State Attorneys General (AGs) play a central role in enforcing cannabis laws and protecting consumers. As legalization continues to sweep the country, the interplay between state and federal law demands particular attention. In this edition of The 411 on 420, Perkins Coie senior counsel Andrew Kline discusses the role of the State AGs with Austin
The Future of Cannabis and Psilocybin as Plant-Based Medicine: A Conversation with Stephen Dahmer and Betty Aldworth
Millions of Americans are utilizing medical cannabis and psilocybin to treat specific medical conditions each day. However, scientific and medical research lags in the U.S. lags behind other nations. Dr. Stephen M. Dahmer, Chief Medical Officer at Vireo Health, and Betty Aldworth, Director of Communications and Events at the Multidisciplinary Association for Psychedelic Studies (MAPS)
Senators Propose Cannabis Descheduling Plan: Five Takeaways for The Cannabis Industry
Last week, Senators Schumer (D-NY), Booker (D-NJ), and Wyden (D-OR) circulated a discussion draft of the Cannabis Administration and Opportunity Act, a legislative proposal to deschedule and legalize cannabis. In related statements to the Senate, Senator Schumer emphasized that cannabis legislation will be prioritized during this Congress, stating “it’s time to end the federal prohibition on marijuana [a]nd as majority leader, I am going to push this issue forward and make it a priority.”
While there is much to explore in the bill’s 163 pages, here are five immediate takeaways for the cannabis industry.
Continue Reading Senators Propose Cannabis Descheduling Plan: Five Takeaways for The Cannabis Industry
Federal Cannabis Descheduling Bill Needs More Clarity
The third version of the Marijuana Opportunity Reinvestment and Expungement, or MORE, Act was introduced on May 28. Perkins Coie lawyers Barak Cohen and Andrew Kline, in partnership with Yoko Miyashita, CEO of Leafly, authored an article discussing the bill. They make the case that Congress should regulate intentionally and make certain that
Packaging and Labeling Post Descheduling: A Conversation with Doug Fischer
It is well known that the varying state regulations for cannabis give this industry a complex legal landscape. Nowhere is that more apparent than in the state regulations related to cannabis packaging and labeling. Perkins Coie senior counsel Andrew Kline is joined by Doug Fischer, General Counsel of Greenlane, the leading global platform for the
The Big Questions Facing Federal Cannabis Legalization: A Conversation with Andrew Freedman, Executive Director of the Coalition for Cannabis Policy, Education, and Regulation (CPEAR)
Perkins Coie senior counsel Andrew Kline is joined by Andrew Freedman, Colorado’s first cannabis czar under Governor Hickenlooper and current Executive Director of the Coalition for Cannabis Policy, Education, and Regulation (CPEAR). Andrew’s role in developing a successful operating model for cannabis regulation and stakeholder collaboration was identified as one of the reasons for the
Delta-8: A New Low in Highs
Most Americans are familiar with the term “THC” at this point. What they might not yet appreciate is that common nomenclature is actually referring to Delta-9-tetrahydrocannabinol or “Delta-9” THC. That’s the scientific terminology for the molecule in marijuana that’s well-known for its psychoactive properties—i.e., what causes a “high.” Delta-9 is a cannabinoid and there are hundreds of different cannabinoids within any given cannabis plant.
Continue Reading Delta-8: A New Low in Highs
The Future of Cannabis: State Legalization and Private Sector Perspective
On March 3, 2021, Perkins Coie partner Barak Cohen moderated a panel to discuss the future of the cannabis industry. Panelists included Michelle Rutter Friberg, Deputy Director of Government Relations at the National Cannabis Industry Association, Steve Hawkins, Executive Director of the Marijuana Policy Project, Yoko Miyashita, Chief Executive Officer of Leafly, and Andrew Kline,
The Future of Cannabis: Federal Perspective
On March 3, 2021, Perkins Coie partner Barak Cohen moderated a panel to discuss the future of the cannabis industry. Panelists included Michelle Rutter Friberg, Deputy Director of Government Relations at the National Cannabis Industry Association, Steve Hawkins, Executive Director of the Marijuana Policy Project, Yoko Miyashita, Chief Executive Officer of Leafly, and Andrew Kline,
Leafly Releases Job Report: Cannabis Job Growth “Astonishing”
Leafly and Whitney Economics have issued an annual jobs report reflecting updated jobs and revenue numbers for the state-legal cannabis industry in 2020. While 2020 will be remembered as the year that a deadly pandemic shuttered thousands of small businesses, it should also be remembered as the year that set the cannabis industry on a path to become a leading economic contributor to the U.S. economy.
Continue Reading Leafly Releases Job Report: Cannabis Job Growth “Astonishing”